Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemoradiation in bladder cancer].

Catherine Durdux1

  • 1Onco-radiothérapie, Hôpital européen Georges Pompidou, 20, rue Leblanc, 75015 Paris. catherine.maulard-durdux@hop.egp.ap-hop-paris.fr

Bulletin Du Cancer
|January 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radionecrosis risk and local control after CyberKnife<sup>®</sup> fractionated stereotactic radiotherapy for brain metastases: an eight-year single-centre cohort.

Radiation oncology (London, England)·2026
Same author

[Special features of radiotherapy in elderly].

La Revue du praticien·2026
Same author

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI).

Clinical and translational radiation oncology·2025
Same author

Multicenter Retrospective Analysis of the Safety and Efficacy of Sacituzumab Govitecan Combined With Radiation Therapy: The French ATTENTION Study.

International journal of radiation oncology, biology, physics·2025
Same author

Radiotherapy and pregnancy: 2025 update.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2025
Same journal

[Update: Evolution in the management of metastatic urothelial carcinomas].

Bulletin du cancer·2026
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
See all related articles

Chemoradiotherapy offers a viable alternative to cystectomy for select invasive bladder cancer patients, potentially preserving the bladder. This treatment involves concurrent cisplatin and radiation, with mid-treatment cystoscopies to assess response and outcomes.

Area of Science:

  • Urologic Oncology
  • Radiation Oncology
  • Medical Oncology

Context:

  • Bladder cancer is a common urologic malignancy.
  • Radical cystectomy is the standard treatment for localized invasive bladder cancer.
  • Bricker's urinary diversion can lead to significant surgical morbidity.

Purpose:

  • To review published data on chemoradiotherapy for invasive bladder cancer.
  • To evaluate chemoradiotherapy as an alternative to cystectomy.
  • To present results on local control, survival, bladder preservation, and toxicity.

Summary:

  • Chemoradiotherapy, using cisplatin concurrently with radiation (60-65 Gy), is a valid alternative to cystectomy for selected patients with invasive bladder cancer.
  • Mid-treatment cystoscopies are used to identify responders and non-responders.

Related Experiment Videos

  • This review summarizes key findings from published series regarding local control, survival rates, bladder preservation, and treatment toxicity.

    • Impact:

    • Chemoradiotherapy can achieve good local control and survival rates in invasive bladder cancer.
    • Bladder preservation is achievable with this approach, avoiding the morbidity of cystectomy and urinary diversion.
    • Understanding treatment response through cystoscopy allows for personalized management strategies.